retatrutide turkey (LY3437943) Understanding Retatrutide: The Triple G

FIGURE 10 Statements Author contributions LL and CL conceived the project and wrote the manuscript

Underestimation of risk : Conversely, they may underestimate the risk in some individuals taking GLP-1s, where varied responses to treatment may lead to diverging outcomes

If a product is investigational, trial enrollment rules may matter more than consumer demand

D.BishtK

Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia